admin – Page 2996 – Get News Story

“I Am Crazy… And You Are, Too!” is a Brutally Honest Book That Says What Everyone Else is Afraid To

What if the thing that makes you feel “off” is actually the only honest part of you left? What if you’ve been faking normal so long you forgot what it feels like to be real?

In I AM CRAZY …AND… YOU ARE TOO!, David Schecter doesn’t hand you a life raft—he hands you a mirror. And it might crack. But that’s the point.

This is not your standard self-help fluff, nor is it a polished memoir pretending to have all the answers. This book is jagged, raw, and startlingly familiar. Schecter peels back the layers of identity, ego, emotional armor, and social performance and exposes the madness that lives just beneath the surface—your surface.

Broken into two bold, confrontational parts, the book begins with a relentless dissection of the self. Schecter forces you to face your excuses, your habits, your thought loops, and your illusions. He speaks directly to the reader like an old friend who’s done pretending—and now, he’s calling you out with love and grit.

The second half shifts the spotlight to the world around us. Family. Relationships. Authority. Society’s unwritten rules. Government. Religion. He pokes at everything you’ve been taught not to question—and shows how we’re all participating in a game we don’t even realize we’re playing.

But what sets this book apart isn’t just its fearless content. It’s the voice. Schecter writes the way real people talk in their own heads—panicked, sarcastic, hopeful, messy, and unexpectedly profound. He doesn’t ask for your trust. He earns it by showing you his own battle scars, admitting his flaws, and asking the questions most people are too scared to ask.

Why do we fear vulnerability so much? Why do we give our lives over to fear, pride, or approval? Why are we so quick to label ourselves broken when maybe—just maybe—we’re just unfiltered?

This isn’t a guidebook. There are no 10 steps. No bullet points. Just a series of deeply personal, often hilarious, and sometimes uncomfortable reflections that will leave you asking one central question:

If I’m not pretending anymore… who am I?

I AM CRAZY …AND… YOU ARE TOO! doesn’t offer easy solutions. It offers freedom. But only if you’re brave enough to stop lying to yourself.

About the Author

David Schecter is not a life coach, not a therapist, and definitely not your typical “expert.” He’s a man who’s lived a thousand lives in one—and came out the other side ready to tell the truth.

Armed with a BSBA in Marketing and an MBA from the University of Denver, Schecter built a professional life that spanned everything from mining to marketing to real estate. He’s held leadership roles in market research, forecasting, and product development, and has worked in shipping, oil, lumber, consumer goods—you name it. He also launched creative projects like cookbooks and calendars and developed multimillion-dollar real estate projects, both residential and industrial.

Entrepreneurial to the core, he once owned a country bar and multiple car washes. He’s also served on nonprofit boards, sat on church councils, and still plays piano and sings in public just for the love of it. As a single father, he coached his sons’ teams and balanced spreadsheets and bedtime stories with equal commitment.

What ties all of this together is his obsession with truth—not the polished, filtered kind, but the kind that makes people uncomfortable—and that makes it real. That’s exactly what he brings to I AM CRAZY …AND… YOU ARE TOO!.

This is not your therapist’s recommended reading. This is the book you read when you’re tired of pretending to have it all together. When you’re ready to sit with your chaos instead of running from it. When you’re ready to admit that maybe being a little “crazy” is the most honest thing about you.

With grit, humor, and a whole lot of humanity, Schecter delivers a work that doesn’t aim to fix anyone—but instead invites everyone to stop hiding. I AM CRAZY …AND… YOU ARE TOO! is a book for the ones who want truth more than comfort—and who are finally ready to meet themselves, without filters.

The book is available now.

To learn more, visit:

https://www.youtube.com/@DavidB.Schecter

https://www.linkedin.com/company/david-b-schecter

https://www.facebook.com/davidbschecter

https://www.instagram.com/davidbschecteroffi/

https://x.com/davidbscheecter

Media Contact
Company Name: Visionary Book Writers
Contact Person: James Allen
Email: Send Email
City: St. Petersburg
State: FL
Country: United States
Website: www.instagram.com/davidbschecteroffi

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: “I Am Crazy… And You Are, Too!” is a Brutally Honest Book That Says What Everyone Else is Afraid To

David Schecter’s New Book Challenges the Illusions People Have Been Hiding Behind

David Schecter’s new book takes an unflinching look at the human condition, offering an honest, raw, and unapologetic exploration of what it truly means to face oneself and the world with eyes wide open. I Am Crazy… And You Are Too! By David Schecter is a thought-provoking work that is not for the faint of heart. Schecter encourages readers to step away from the comfort of denial and self-deception, daring them to engage with uncomfortable truths.

In a world where illusions run rampant, I Am Crazy… And You Are Too! is a call to arms for anyone ready to confront the things they’ve been avoiding. The book is divided into two bold parts. The first is all about you—your thoughts, your ego, and your emotional habits. The things we often hide from ourselves. The second part is a bold exploration of others: relationships, society, and the systems we accept without question.

Throughout the book, Schecter delivers a challenging message that isn’t sugar-coated or wrapped in feel-good fluff. Instead, it’s blunt and to the point. His tone is both tough and caring, shaking you awake to the reality of your behaviors, attitudes, and choices. “We are all a bit crazy,” he writes, “and it’s time we stopped pretending otherwise.”

Schecter doesn’t just tell you you’re messed up—he tells you why. And he does it with humor, insight, and a deep understanding of human nature. By challenging the way we view ourselves and others, I Am Crazy… And You Are Too! opens up the possibility for real personal growth. But, as Schecter makes clear, growth is never comfortable. It requires us to face our egos, our fears, and the lies we tell ourselves.

While many self-help books promise easy answers, this one doesn’t pretend to have all the solutions. It’s about asking the right questions—and daring to look for the answers even when they challenge your entire worldview. I Am Crazy… And You Are Too! makes the reader wrestle with themselves, their choices, and the world around them.

About the Author:

David Schecter is a seasoned professional with an impressive career background that spans across many industries. He holds a BSBA in Marketing and an MBA from the University of Denver. Over the course of his career, he has accumulated more than five years of experience in corporate roles, including market research, development, and forecasting. His work spans industries like mining, oil, lumber, shipping, and consumer goods, as well as creating cookbooks, calendars, and developing industrial and residential real estate.

Schecter is no stranger to entrepreneurship, having owned businesses such as a country bar and multiple car washes. He has also served on nonprofit boards and church councils and continues to stay actively involved in real estate projects worth millions. As a single father, Schecter balanced his professional life with his family life, coaching his sons’ sports teams for many years, always putting family first. In addition to his professional endeavors, he has a passion for music and performs piano and sings in public.

These diverse experiences have shaped Schecter’s perspective on conformity and government, and in I Am Crazy… And You Are, too!, he encourages readers to be true to themselves. He urges individuals to think for themselves, choose personal truth, and avoid seeking social approval.

Final Thoughts:

If you’re ready to stop pretending everything is fine, if you’re done with half-truths, and if you’re ready to meet the real you head-on, this book was written for you. With humor, wisdom, and a touch of tough love, Schecter offers the kind of life-changing insight that doesn’t just skim the surface—it digs deep.

Get ready to laugh, wince, and maybe even feel a little uncomfortable. But most importantly, get ready to discover the truth about yourself—and the world around you. Because once you’ve seen the truth, you can never go back.

I Am Crazy… And You Are Too! is available now.

To learn more, visit:

https://www.youtube.com/@DavidB.Schecter

https://www.linkedin.com/company/david-b-schecter

https://www.facebook.com/davidbschecter

https://www.instagram.com/davidbschecteroffi/

https://x.com/davidbscheecter

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: David Schecter’s New Book Challenges the Illusions People Have Been Hiding Behind

Treg Cell-Based Therapies Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Rapa Therapeutics, Orca Bio, Caladrius Biosciences, Sangamo Therapeut

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Treg Cell-Based Therapies pipeline constitutes key 51+ companies continuously working towards developing 55+ Treg Cell-Based Therapies treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.

The Treg Cell-Based Therapies Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.

“Treg Cell-Based Therapies Pipeline Insight, 2025“ report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Treg Cell-Based Therapies Market.

Some of the key takeaways from the Treg Cell-Based Therapies Pipeline Report:

Companies across the globe are diligently working toward developing novel Treg Cell-Based Therapies treatment therapies with a considerable amount of success over the years.
Treg Cell-Based Therapies companies working in the treatment market are HCW Biologics, Sangamo Therapeutics, Gentibio, Abata Therapeutics, NightHawk Biosciences, Quell Therapeutics Limited, Coya Therapeutics, Orca Bio, Caladrius Biosciences, VT BIO, Cellenkos, and others, are developing therapies for the Treg Cell-Based Therapies treatment

Emerging Treg Cell-Based Therapies therapies in the different phases of clinical trials are- HCW9302, KITE-037, GNTI-122, ABA-101, PTX-35, TX200, QEL-001, Coya 101, Orca-T, CLBS03, VT301, CK0804, and others are expected to have a significant impact on the Treg Cell-Based Therapies market in the coming years.
In October 2024, Quell Therapeutics joined forces with eXmoor Pharma to manufacture its CAR-Treg immunosuppressive cell therapies at eXmoor’s newly established cell and gene therapy facility. This partnership, forming part of a strategic alliance between the two UK-based companies, will support the production of Quell’s investigational cell therapies for autoimmune diseases intended for use in early-phase clinical trials.
In September 2024, Abata Therapeutics announced that the US FDA has granted fast track designation to ABA-101, an autologous regulatory T-cell (Treg) therapy developed for the treatment of patients with progressive multiple sclerosis (MS).
In September 2024, PolTREG S.A. announced that the China National Intellectual Property Administration (CNIPA) has granted a patent for its method of intrathecal administration of cellular therapies in multiple sclerosis (MS) patients. This technique involves delivering treatment directly into the subarachnoid space, allowing it to cross the blood-brain barrier effectively.
In May 2024, Orca Bio announced the presentation of new data at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois, from May 31–June 4. The presentation highlighted outcomes of its lead investigational allogeneic T-cell immunotherapy, Orca-T, in patients with acute myeloid leukemia (AML).

Treg Cell-Based Therapies Overview

Treg cell-based therapies involve using regulatory T cells (Tregs) to treat various autoimmune and inflammatory diseases. Tregs are a specialized subset of T cells that play a crucial role in maintaining immune tolerance and preventing autoimmune responses. These therapies harness the natural suppressive functions of Tregs to modulate the immune system and restore balance.

Get a Free Sample PDF Report to know more about Treg Cell-Based Therapies Pipeline Therapeutic Assessment-

https://www.delveinsight.com/report-store/treg-cell-based-therapies-pipeline-insight

Emerging Treg Cell-Based Therapies Drugs Under Different Phases of Clinical Development Include:

HCW9302: HCW Biologics
KITE-037: Sangamo Therapeutics
GNTI-122: Gentibio
ABA-101: Abata Therapeutics
PTX-35: NightHawk Biosciences
TX200: Sangamo Therapeutics
QEL-001: Quell Therapeutics Limited
Coya 101: Coya Therapeutics
Orca-T: Orca Bio
CLBS03: Caladrius Biosciences
VT301: VT BIO
CK0804: Cellenkos

Treg Cell-Based Therapies Pipeline Therapeutics Assessment

Treg Cell-Based Therapies Assessment by Product Type
Treg Cell-Based Therapies By Stage and Product Type
Treg Cell-Based Therapies Assessment by Route of Administration
Treg Cell-Based Therapies By Stage and Route of Administration
Treg Cell-Based Therapies Assessment by Molecule Type
Treg Cell-Based Therapies by Stage and Molecule Type

DelveInsight’s Treg Cell-Based Therapies Report covers around 55+ products under different phases of clinical development like

Late-stage products (Phase III)
Mid-stage products (Phase II)
Early-stage product (Phase I)
Pre-clinical and Discovery stage candidates
Discontinued & Inactive candidates
Route of Administration

Further Treg Cell-Based Therapies product details are provided in the report. Download the Treg Cell-Based Therapies pipeline report to learn more about the emerging Treg Cell-Based Therapies therapies

Some of the key companies in the Treg Cell-Based Therapies Therapeutics Market include:

Key companies developing therapies for Treg Cell-Based Therapies are – Rapa Therapeutics, Orca Bio, Caladrius Biosciences, Sangamo Therapeutics, Quell Therapeutics, Coya Therapeutics, Sonoma Biotherapeutics, GentiBio, AstraZeneca, TCR² Therapeutics, Cellenkos, VT BIO, KSQ Therapeutics, Kyverna Therapeutics, Astellas, Abata Therapeutics, TRACT Therapeutics, Adaptive Biotechnologies, PolTREG, TeraImmune, and others.

Treg Cell-Based Therapies Pipeline Analysis:

The Treg Cell-Based Therapies pipeline report provides insights into

The report provides detailed insights about companies that are developing therapies for the treatment of Treg Cell-Based Therapies with aggregate therapies developed by each company for the same.
It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Treg Cell-Based Therapies Treatment.
Treg Cell-Based Therapies key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
Treg Cell-Based Therapies Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Treg Cell-Based Therapies market.

The report is built using data and information traced from the researcher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

Download Sample PDF Report to know more about Treg Cell-Based Therapies drugs and therapies

Treg Cell-Based Therapies Pipeline Market Drivers

High prevalence of autoimmune and inflammatory diseases, the emergence of new techniques such as next-generation T-cells immunotherapy are some of the important factors that are fueling the Treg Cell-Based Therapies Market.

Treg Cell-Based Therapies Pipeline Market Barriers

However, high cost associated with the Treg Cell-Based Therapies, the complex manufacturing of regulatory T-cell immunotherapies and other factors are creating obstacles in the Treg Cell-Based Therapies Market growth.

Scope of Treg Cell-Based Therapies Pipeline Drug Insight

Coverage: Global
Key Treg Cell-Based Therapies Companies: HCW Biologics, Sangamo Therapeutics, Gentibio, Abata Therapeutics, NightHawk Biosciences, Quell Therapeutics Limited, Coya Therapeutics, Orca Bio, Caladrius Biosciences, VT BIO, Cellenkos, and others
Key Treg Cell-Based Therapies Therapies: HCW9302, KITE-037, GNTI-122, ABA-101, PTX-35, TX200, QEL-001, Coya 101, Orca-T, CLBS03, VT301, CK0804, and others
Treg Cell-Based Therapies Therapeutic Assessment: Treg Cell-Based Therapies current marketed and Treg Cell-Based Therapies emerging therapies
Treg Cell-Based Therapies Market Dynamics: Treg Cell-Based Therapies market drivers and Treg Cell-Based Therapies market barriers

Request for Sample PDF Report for Treg Cell-Based Therapies Pipeline Assessment and clinical trials

Table of Contents

1. Treg Cell-Based Therapies Report Introduction

2. Treg Cell-Based Therapies Executive Summary

3. Treg Cell-Based Therapies Overview

4. Treg Cell-Based Therapies- Analytical Perspective In-depth Commercial Assessment

5. Treg Cell-Based Therapies Pipeline Therapeutics

6. Treg Cell-Based Therapies Late Stage Products (Phase II/III)

7. Treg Cell-Based Therapies Mid Stage Products (Phase II)

8. Treg Cell-Based Therapies Early Stage Products (Phase I)

9. Treg Cell-Based Therapies Preclinical Stage Products

10. Treg Cell-Based Therapies Therapeutics Assessment

11. Treg Cell-Based Therapies Inactive Products

12. Company-University Collaborations (Licensing/Partnering) Analysis

13. Treg Cell-Based Therapies Key Companies

14. Treg Cell-Based Therapies Key Products

15. Treg Cell-Based Therapies Unmet Needs

16 . Treg Cell-Based Therapies Market Drivers and Barriers

17. Treg Cell-Based Therapies Future Perspectives and Conclusion

18. Treg Cell-Based Therapies Analyst Views

19. Appendix

20. About DelveInsight

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Treg Cell-Based Therapies Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Rapa Therapeutics, Orca Bio, Caladrius Biosciences, Sangamo Therapeut

Black Diamond Spas Relocates to a Larger Showroom in Clay Cross, Derbyshire

Derbyshire, UK – Black Diamond Spas, a well-established name in the UK’s hot tub and swim spa industry, is pleased to announce the relocation of its headquarters and showroom to a new, larger facility in Clay Cross, Derbyshire. The move enables the company to better serve customers across Derbyshire and the wider UK, with full details available on the Black Diamond Spas website.

Although the relocation to the new showroom took place in September 2024, the official reopening to the public was delayed due to the scale of the operation. Now fully operational, the new headquarters marks a significant step forward in Black Diamond Spas’ continued national growth and commitment to customer care.

The new premises, located at Unit 3 Wingfield Court, Clay Cross, Chesterfield, Derbyshire, S45 9JA, has an expanded showroom showcasing the company’s best-selling models from 2 Seater hot tubs to dual-zone swim spas. Multiple wet test zones allow customers to experience various spa options in a dedicated, purpose-built environment.

This relocation further strengthens the company’s presence in the Derbyshire region. With improved logistics and warehousing, Black Diamond Spas is now better positioned to offer affordable but luxury solutions across Clay Cross, Chesterfield, Alfreton, Matlock, and beyond — all while maintaining product quality and reliable service.

Managing Director James Day showed his pride in the company’s local roots:

“It’s a great feeling to have built a business right here in the area where I grew up. As someone who’s local to the community, it brings us immense pride to operate and contribute to our hometown. It means a lot to see familiar faces – people I’ve known for many years – acknowledge the hard work we put in. Our goal is to continue offering more members of our local community secure, long-term employment in a supportive and positive workplace.”

Co-Managing Director Jake Keller added:

“This achievement is the result of years of hard work and dedication. We’re proud to offer our products nationwide, with positive feedback from customers across the UK. Our brand has become widely recognised, and we remain committed to delivering both high-quality products and exceptional service.”

Strategically located in the heart of the UK, the new Clay Cross headquarters enables Black Diamond Spas to offer nationwide delivery, installation, and aftercare. Whether it’s a swim spa in Scotland or an Air Source Heat Pump in Cornwall, the team ensures a seamless customer experience from start to finish.

James concluded: “We love seeing people visit the new showroom — whether it’s to browse chemicals and filters, explore new spas, or simply say hello. Everyone’s welcome to come by, take a look around, and enjoy a coffee with the team.”

Since relocating, Black Diamond Spas has used the move to modernise operations and expand its reach, welcoming more customers into the Black Diamond family than ever before.

To find out more, visit the new Clay Cross showroom.

Media Contact
Company Name: Black Diamond Spas
Contact Person: Olli Allen
Email: Send Email
Phone: 01246261807
Address:Unit 3 Wingfield Court, Clay Cross, Chesterfield
City: Derbyshire, S45 9JA
State: GB
Country: United Kingdom
Website: https://blackdiamondspas.co.uk/

Veteran Maid House Cleaning Expands Expert Cleaning Solutions in Pensacola

Veteran Maid House Cleaning proudly announces the expansion of its premier cleaning services, catering to residential and commercial clients across the Pensacola area. Known for a commitment to quality and reliability, Veteran Maid House Cleaning offers specialized solutions tailored to meet the diverse needs of homes, vacation rentals, and businesses.

Veteran Maid House Cleaning delivers top-tier Commercial Cleaning Services Pensacola designed to maintain clean and sanitary workplaces. These services focus on enhancing operational environments with thorough, professional cleaning that supports health and productivity. Businesses benefit from flexible scheduling and detailed cleaning protocols crafted to industry standards.

For property owners managing short-term rentals, the company offers an exceptional Airbnb Cleaning Service Pensacola. This service ensures that each property is impeccably prepared for guest arrivals, with meticulous attention to detail that enhances guest satisfaction and fosters positive reviews. Rapid turnaround times and dependable service provide hosts with peace of mind.

Homeowners can rely on Veteran Maid House Cleaning for comprehensive House Cleaning Services Pensacola. These services encompass routine cleaning as well as deep cleans, emphasizing meticulous care in every room. The trusted team uses effective, eco-friendly products to deliver safe and healthy living spaces.

Veteran Maid House Cleaning stands out through its dedication to integrity, professionalism, and consistent results. The company continues to set a high standard for cleaning services in Pensacola, reflecting a strong work ethic and a commitment to meeting client expectations.

Media Contact
Company Name: Veteran Maid House Cleaning
Contact Person: Chad Overly
Email: Send Email
Phone: (850) 407-6685
Address:12591 Prospero Dr
City: Pensacola
State: FL 32506
Country: United States
Website: https://www.veteranmaid.com/

Peterson Painting Announces Expansion of Service Offerings in Windsor Heights

Peterson Painting has unveiled a strategic enhancement of service offerings to meet evolving project demands across the Windsor Heights community. Drawing upon deep regional expertise, the company has restructured its teams and refined its methods to deliver exceptional results on every assignment.

Enhanced Interior Painting Capabilities

A dedicated Interior Painters Windsor Heights division now brings focused attention to surface preparation, precise color matching, and finish coatings. Licensed professionals utilize premium materials and established techniques, such as step-by-step drywall patching, careful primer application, and smooth topcoats, to breathe new life into living spaces, office interiors, and specialty properties.

Strengthened Exterior Division

The expanded Outside Painters Windsor Heights crews are equipped for complete façade refinishing, trim restoration, and weather-resistant treatments. Meticulous substrate preparation and high-performance coatings help protect structures against moisture and sun exposure, preserving architectural details and enhancing curb appeal throughout residential neighborhoods.

Professional Drywall Repair Services

Perfect paintwork begins with flawless walls. To ensure ideal surfaces, Peterson Painting highlights its Drywall Repair Windsor Heights expertise. Skilled technicians address cracks, nail pops, and uneven joints using precision taping, compound application, and sanding, creating smooth, paint-ready walls that withstand scrutiny.

Community Commitment and Recognition

Peterson Painting remains deeply rooted in the Windsor Heights community, recognized locally for reliability, safety, and clear communication. Every project adheres to building codes and lead-safe renovation standards, reflecting a commitment to neighborhood wellbeing and property improvements that last.

About Peterson Painting

Operating from Windsor Heights, Peterson Painting delivers comprehensive interior and exterior painting, drywall and plaster repairs, wallpaper installation and removal, and carpentry services. Fully licensed and insured, the company values transparency, punctuality, and respect for each property. Through community-focused projects and meticulous attention to detail, Peterson Painting continues to support a vibrant and well-maintained Windsor Heights.

Media Contact
Company Name: Peterson Painting
Contact Person: Cary Peterson
Email: Send Email
Phone: (515) 274-1883
Address:2110 63rd St
City: Windsor Heights
State: IA 50324
Country: United States
Website: http://www.petersonpainting.net/

From the Chishui River to Osaka Bay, Moutai’s ESG Practices Create a Global Resonance of “Green Mountains and Clear Waters”

As the rich aroma of the Chishui River “drifts” to Osaka Bay, the millennia-old culture of Chinese baijiu meets modern sustainable development concepts here. As the ripples of the Chishui River “flow” into the China Pavilion, the green wisdom of Guizhou, China, engages in dialogue with global ecological civilization.

At the 2025 World Expo in Osaka, Japan (referred to as the “Osaka Expo”), Moutai held a “Theme Day” event, themed “Osaka 2025: Moutai, Celebrating 110 Years with the World,” showcasing its innovative practices in the fields of Environment, Social, and Governance (ESG) to contribute “Eastern wisdom” to global sustainable development.

Harmony Between Humanity and Nature: The “Green Gene” of a “Glass of Liquor”

Inside the China Pavilion, Moutai used immersive digital displays to allow visitors to “travel” through time and space to the Chishui River Valley: dense forests monitored by drones, clean factories powered by solar panels, brewery wastewater treated with microbial technology, and drone swarms gliding like migratory birds over the 15.03 square kilometer core production area, with infrared cameras capturing the traces of the elusive clouded leopard; brewing waste flowing into a circular industrial park, transforming into biomass energy to light up thousands of homes…

Behind this harmonious scene lies an “ecological report card”: investment in the “Moutai Circular Economy Industrial Park,” achieving 100% resource utilization of brewing waste; the establishment of a “Smart Energy” system that reduces carbon dioxide emissions by over 10,000 tons annually; implementation of ecological protection actions in the Chishui River basin to keep the “Liquor River” vibrant forever…

In the visual interactive exhibition area of the China Pavilion, Moutai’s meticulously crafted ecological art installation, “Mountain Memory,” became the focal point. This installation uses Moutai’s spent grains recycled paper as the main material and employs the visual language of the classic “Moutai bottle” to transform the recycling of brewing by-products into perceptible ecological art, perfectly resonating with the green development theme of the China Pavilion: “Building a Community of Life between Humanity and Nature.”

Moutai achieves 100% resource utilization of the spent grains produced during its brewing process each year through technological innovation. The development of recycled paper from spent grains not only addresses the solid waste disposal challenges of traditional brewing but also imbues waste materials with artistic life. This practice vividly embodies Moutai’s “Green Production Area” concept—promoting low-carbon circularity across the entire industrial chain, from raw materials to by-products, while safeguarding the irreplaceable ecological secrets of the Chishui River. After the exhibition, the installation will return to Moutai’s permanent collection, serving as a physical testament to the company’s green transformation and continuing the sustainable vision of the Expo to “Design the Future Society.” Through this installation, Moutai elevates the ecological practices of the brewing industry into cultural expression, demonstrating that traditional industries can also be pioneers of the green revolution—not only crafting fine spirits but also nurturing a harmonious future between humanity and nature.

Civilizational Dialogue: The “Global Resonance” of “Green Mountains and Clear Waters”

The story of Moutai is not only a millennia-old narrative of coexistence between humanity and nature but also a cultural legend of friendship and emotional resonance between China and the world.

A bond that transcends borders conveys the deep connections between Moutai, the Expo, and Japan, becoming a unique symbol of cultural exchange between China and Japan.

At the launch ceremony of the Moutai Expo commemorative liquor, memories of the Expos from 1915 in San Francisco, 2010 in Shanghai, to 2025 in Osaka unfolded, ultimately showcasing a fine spirit embraced by a metallic landscape. Inspired by the “bamboo scroll” of the China Pavilion, this commemorative liquor features famous quotes from the Analects engraved on the glazed bottle. The gift box, made from natural bamboo, reflects the timeless essence of “Chinese book scrolls.” When the three-dimensional scene is fully presented, the metallic landscape captures the artistic representation of “Green Mountains and Clear Waters” found within the China Pavilion.

At this moment, the Eastern wisdom of “Harmony between Heaven and Humanity” transcends mountains and seas, radiating new vitality in a global context. This is not only an artistic interpretation of the Expo’s theme but also a profound dialogue between Moutai’s philosophy of “Following Heaven and Respecting Humanity” and global sustainable development concepts. As friends from both China and abroad witness the birth of the Moutai Expo commemorative liquor, Eastern and Western civilizations achieve a beautiful resonance on the shared human theme of “Protecting Our Earth.”

Shared Responsibility and Win-Win Outcomes: From “Rural Common Prosperity” to “Global Initiatives”

As a leading enterprise in China’s baijiu industry, Moutai has always regarded rural revitalization as a core mission of its development. With a commitment to “industrial support for agriculture,” Moutai has explored a sustainable development path for “rural common prosperity.” In areas like Renhuai and Daozhen in Guizhou, Moutai has innovatively implemented a “Company + Base + Farmers” model, establishing hundreds of thousands of acres of organic sorghum planting bases. The company provides seeds, organic fertilizers, and technical guidance for free, ensuring that farmers achieve an average annual income increase of over 4,000 yuan, truly realizing the vision of “one sorghum seed paves the way for rural prosperity.”

Moutai showcases to the world the “Two Mountains” transformation path of ecological protection and industrial symbiosis in the Chishui River basin. It also promotes the establishment of the Chishui River Ecological Public Welfare Fund, collaborating with liquor enterprises from Yunnan, Guizhou, and Sichuan to build an ecological defense line. Furthermore, Moutai has risen to a BBB rating in the MSCI ESG ratings, ranking first in China’s baijiu industry, and has been recognized as an EFQM Global “Seven Stars” enterprise, highlighting its global benchmark status in the field of sustainable development.

From the “rural common prosperity” in the mountainous regions of Guizhou to global ESG initiatives, Moutai has built a responsible ecosystem of harmonious coexistence between the enterprise, society, and nature with its core values of “Following Heaven and Respecting Humanity, Enlightenment and Virtue.” In the future, Moutai will continue to deepen the practice of “Green Mountains and Clear Waters are as Valuable as Mountains of Gold and Silver,” allowing the “Chinese solution” for rural revitalization to shine alongside Moutai’s “wisdom” for global sustainable development, writing a broader chapter of shared responsibility and win-win outcomes.

As the Osaka Expo gains momentum, the Moutai booth has become a popular spot for visitors from various countries—here, the rich aroma of the sauce fragrance not only fills the air but also conveys an Eastern vision of “green development for a sustainable future.”

Media Contact
Company Name: Moutai
Contact Person: Alex lu
Email: Send Email
City: Osaka
Country: Japan
Website: https://www.moutaichina.com

Three Decades of Craftsmanship and Vision – MK Masterwork Celebrates 30th Anniversary with Global Customer Conference

On May 8, Masterwork Group Co., Ltd. (hereinafter “MK Masterwork”) hosted its landmark 30th Anniversary Customer Conference in Tianjin. The event brought together more than 500 participants — including representatives from over 200 international clients, industry association leaders, and sector experts — to commemorate MK Masterwork’s three-decade journey of innovation and partnership. Centered on the theme “Boundless Innovation, Connected Ecosystem,” the conference highlighted MK Masterwork’s upgraded full-industry-chain strategy and charted a forward-looking path toward a greener, smarter future in printing and packaging.

Three Decades of Customer-Driven Innovation: Shaping the Industry Standard

During the conference, Chairperson Li Li underscored that MK Masterwork’s development over the past 30 years has been rooted in a steadfast commitment to customer needs. From its origins as a manufacturer of independent printing machines, the company has evolved into a comprehensive provider of over 100 products across seven core series — becoming the industry’s only end-to-end solution supplier for printing and packaging. This transformation has been driven by core values of continuous innovation, uncompromising quality, customer-oriented service, and business integrity.

“Every technological breakthrough at MK Masterwork is born from the practical challenges faced by our clients on the production line,” Li Li remarked. To date, MK Masterwork holds over 500 patents. Its pioneering technologies — such as sheet-fed die-cutting with foil stamping and roll-fed die-cutting — have disrupted longstanding international monopolies. With exports reaching more than 100 countries and regions, MK Masterwork’s innovations span high-end markets like tobacco and pharmaceutical packaging as well as fast-growing sectors such as food packaging and new energy materials. By focusing on the critical pain points of its customers, MK Masterwork continues to enhance client competitiveness through cutting-edge solutions.

Global Launch of Four Breakthrough Products: Eliminating Industry Bottlenecks and Reimagining the Production Ecosystem

To tackle the persistent “breakpoints” plaguing the printing and packaging industry — including fragmented processes, data silos, and disjointed resource integration — MK Masterwork unveiled four groundbreaking new products at the conference. These innovations integrate equipment, intelligent systems, and interconnected ecosystems to overcome efficiency barriers and redefine the industry’s production landscape.

1. MK 3920FFCSB Tripress hot foil stamping and die cutting machine with stripping and blanking

oInnovation Rationale: Featuring a modular architecture, this system seamlessly integrates die-cutting, foil stamping, and waste stripping into a unified platform — eliminating inefficiencies associated with multi-machine workflows. By bridging process discontinuities, it delivers a performance boost of over 30%.

2. MK1060CB Die Cutting With Blanking Machine

oPrecision Engineering: Tailored for pharmaceutical packaging, this model utilizes a dual-blade configuration to streamline complex production flows. Its design philosophy of “process subtraction” removes redundant steps, making it ideal for high-purity, contamination-sensitive environments.

3. MK920DVF Digital Enhancement Machine

oDigital Innovation: Equipped with advanced variable data foil stamping capabilities, this machine resolves the productivity challenges of short-run and highly customized orders. By fusing digital technology with traditional craftsmanship, it enables agile manufacturing and empowers clients to compete in the growing personalization market.

4. Next-Generation Qingmou Inspection System

oRevolution in Quality Assurance: Utilizing AI-powered visual algorithms and high-speed image capture, this system performs real-time defect detection across intricate production stages. By bridging the disconnect between production and quality control, it reduces scrap rates to below 0.1%.

“We’re not merely delivering equipment — we’re enabling our clients to ‘unblock the arteries’ of their production systems,” said Maxen Liu General Manager of Sales at MK Masterwork. “Each of these innovations is purpose-built to address critical breakpoints, minimize hidden costs, and elevate operational efficiency across the entire value chain.”

New Products + New Ecosystem: Shaping a Framework of Certainty for the Printing Industry

In addition to product breakthroughs, MK Masterwork introduced three strategic initiatives aimed at building an integrated, full-cycle value system combining equipment, services, and a collaborative ecosystem.

Innovative Leasing Models: MK Masterwork introduced on-demand leasing for AGVs and QR code–based leasing for coding machines. This “asset-light” approach significantly reduces the financial burden of smart upgrades for clients, while boosting equipment utilization rates by more than 40%.
Expanded Industrial Ecosystem: MK Masterwork Green Packaging has entered the sustainable packaging sector with new ventures in paper bottle production. Meanwhile, Jiangsu MK Masterwork Green Energy has launched high-performance photovoltaic modules, marking the company’s strategic expansion into the new energy materials market.
Next-Generation System Enablement: MK Masterwork unveiled High MK Masterwork and Rong Lite, two open-source, lightweight management platforms designed for modern printing facilities. These systems close the loop from equipment to data to operational control. In parallel, the company announced the development of AI-powered solutions, targeting “self-evolving” production lines within three years — giving each machine an adaptive, intelligent core.

“As we look ahead to the next 30 years, MK Masterwork will evolve from an equipment supplier into a builder of ecosystems for the printing industry,” said a company representative. “We aim to go beyond providing machines — delivering integrated solutions that combine products, service models, and ecosystem design to help our clients thrive with confidence in an unpredictable market landscape.”

A New Chapter at 30: Partnering with Customers Toward a Connected, Intelligent Future

Media Contact
Company Name: MK Masterwork
Contact Person: SelinaWang
Email: Send Email
Country: China
Website: https://www.masterworkgroup.com/

Checkpoint Inhibitor Refractory Cancer Market Anticipated to Expand Rapidly During 2023-2032, Says DelveInsight | Checkmate Pharma, BIOCAD, 3D Medicines, OncoSec Medical, CatalYm, BerGenBio

The Key Checkpoint Inhibitor Refractory Cancer Companies in the market include – OncoSec Medical, CatalYm, BerGenBio, Checkmate Pharmaceuticals, BIOCAD, 3D Medicines, Innovent Biologics, EMD Serono/Merck, Aurigene Discovery Technologies, CanBas Co., Ltd, Agenu, Laekna Therapeutics, BeBetter Med, Hangzhou Sumgen Biotech, Harbour BioMed, Phio Pharmaceuticals, and others.

DelveInsight’s “Checkpoint Inhibitor Refractory Cancer Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Checkpoint Inhibitor Refractory Cancer, historical and forecasted epidemiology as well as the Checkpoint Inhibitor Refractory Cancer market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

To Know in detail about the Checkpoint Inhibitor Refractory Cancer market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Checkpoint Inhibitor Refractory Cancer Market Forecast

Some of the key facts of the Checkpoint Inhibitor Refractory Cancer Market Report:

The Checkpoint Inhibitor Refractory Cancer market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
In March 2025, The combination of integrin αvβ8 and αvβ1 inhibitor PLN-101095 with pembrolizumab (Keytruda) was found to be generally well tolerated and showed promising early signs of efficacy in patients with advanced solid tumors that were resistant to prior immune checkpoint inhibitors. Interim results from the ongoing phase 1a/b trial (NCT06270706) revealed that in cohort 3, where six patients received pembrolizumab alongside the highest tested dose of PLN-101095 (1000 mg twice daily), an overall response rate (ORR) of 50% was achieved.
In 2021, there were 158,436 individuals who received treatment for 7MM incident cases of checkpoint inhibitor-resistant infections, with the majority of those cases occurring in the US. There were 64,487 cases in the EU5 nations in 2021.In 2021, Japan had 29,362 instances. By aggregating the cases in various nations, the total incident cases of checkpoint-inhibitor treated patients in 7MM is calculated
NSCLC had the highest incidence in the US in 2021, with 197,496 cases, and it is predicted that number will rise to 242,279 cases by 2032. Merkel cell carcinoma has the fewest cases (2,646 instances), although that number is expected to rise to 2,845 cases by 2032
Merkel cell cancer has the lowest rate of Checkpoint-Inhibitor refractory cases, with 106 cases in the US in 2021 and a projected increase to 114 cases by 2032.
Key Checkpoint Inhibitor Refractory Cancer Companies: OncoSec Medical, CatalYm, BerGenBio, Checkmate Pharmaceuticals, BIOCAD, 3D Medicines, Innovent Biologics, EMD Serono/Merck, Aurigene Discovery Technologies, CanBas Co., Ltd, Agenu, Laekna Therapeutics, BeBetter Med, Hangzhou Sumgen Biotech, Harbour BioMed, Phio Pharmaceuticals, and others
Key Checkpoint Inhibitor Refractory Cancer Therapies: Tavo + Pembrolizumab, CTL-002, Bemcentinib + Pembrolizumab, CMP-001 + Nivolumab, BCD-100, Envafolimab, IBI310, Bintrafusp alfa, CA-170, CBP501, Botensilimab, FAZ053, BEBT-260, SG 12473, HBM-9027, PH-3861, and others
The American Cancer Society estimates that in the US in 2021, there will be roughly 106,110 new cases of melanomas, out of which 7,180 individuals are projected to die. Over the past few decades, melanoma rates have been sharply increasing
The Checkpoint Inhibitor Refractory Cancer market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Checkpoint Inhibitor Refractory Cancer pipeline products will significantly revolutionize the Checkpoint Inhibitor Refractory Cancer market dynamics.

Checkpoint Inhibitor Refractory Cancer Overview

Drugs that block immunological checkpoints are known as immune checkpoint inhibitors. These medications enable immune cells to react to cancer more forcefully by inhibiting them. As a result, the T-cells are able to destroy cancer cells because the “off”signal is not sent.

Get a Free sample for the Checkpoint Inhibitor Refractory Cancer Market Report

https://www.delveinsight.com/report-store/checkpoint-inhibitor-refractory-cancer-market

Checkpoint Inhibitor Refractory Cancer Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Checkpoint Inhibitor Refractory Cancer Epidemiology Segmentation:

The Checkpoint Inhibitor Refractory Cancer market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:

Total Prevalence of Checkpoint Inhibitor Refractory Cancer
Prevalent Cases of Checkpoint Inhibitor Refractory Cancer by severity
Gender-specific Prevalence of Checkpoint Inhibitor Refractory Cancer
Diagnosed Cases of Episodic and Chronic Checkpoint Inhibitor Refractory Cancer

Download the report to understand which factors are driving Checkpoint Inhibitor Refractory Cancer epidemiology trends @ Checkpoint Inhibitor Refractory Cancer Epidemiology Forecast

Checkpoint Inhibitor Refractory Cancer Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Checkpoint Inhibitor Refractory Cancer market or expected to get launched during the study period. The analysis covers Checkpoint Inhibitor Refractory Cancer market uptake by drugs, patient uptake by therapies, and sales of each drug.

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Checkpoint Inhibitor Refractory Cancer Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Checkpoint Inhibitor Refractory Cancer Therapies and Key Companies

Tavo + Pembrolizumab: OncoSec Medical
CTL-002: CatalYm
Bemcentinib + Pembrolizumab: BerGenBio
CMP-001 + Nivolumab: Checkmate Pharmaceuticals
BCD-100: BIOCAD
Envafolimab: 3D Medicines
IBI310: Innovent Biologics
Bintrafusp alfa: EMD Serono/Merck
CA-170: Aurigene Discovery Technologies
CBP501: CanBas Co., Ltd
Botensilimab: Agenu
FAZ053: Laekna Therapeutics
BEBT-260: BeBetter Med
SG 12473: Hangzhou Sumgen Biotech
HBM-9027: Harbour BioMed
PH-3861: Phio Pharmaceuticals

Discover more about therapies set to grab major Checkpoint Inhibitor Refractory Cancer market share @ Checkpoint Inhibitor Refractory Cancer Treatment Market

Checkpoint Inhibitor Refractory Cancer Market Strengths

The potential benefit of Immune Checkpoint Inhibitors is widespread across most cancer types and an unprecedented number of clinical studies are underway to examine the benefit of these agents.

Checkpoint Inhibitor Refractory Cancer Market Opportunities

The frequency of immune-related adverse events (irAEs) is dependent on the agents used, exposure time and the administered dose but also on the patient’s intrinsic risk factors.

Scope of the Checkpoint Inhibitor Refractory Cancer Market Report

Study Period: 2019–2032
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
Key Checkpoint Inhibitor Refractory Cancer Companies: OncoSec Medical, CatalYm, BerGenBio, Checkmate Pharmaceuticals, BIOCAD, 3D Medicines, Innovent Biologics, EMD Serono/Merck, Aurigene Discovery Technologies, CanBas Co., Ltd, Agenu, Laekna Therapeutics, BeBetter Med, Hangzhou Sumgen Biotech, Harbour BioMed, Phio Pharmaceuticals, and others
Key Checkpoint Inhibitor Refractory Cancer Therapies: Tavo + Pembrolizumab, CTL-002, Bemcentinib + Pembrolizumab, CMP-001 + Nivolumab, BCD-100, Envafolimab, IBI310, Bintrafusp alfa, CA-170, CBP501, Botensilimab, FAZ053, BEBT-260, SG 12473, HBM-9027, PH-3861, and others
Checkpoint Inhibitor Refractory Cancer Therapeutic Assessment: Checkpoint Inhibitor Refractory Cancer current marketed and Checkpoint Inhibitor Refractory Cancer emerging therapies
Checkpoint Inhibitor Refractory Cancer Market Dynamics: Checkpoint Inhibitor Refractory Cancer market drivers and Checkpoint Inhibitor Refractory Cancer market barriers
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
Checkpoint Inhibitor Refractory Cancer Unmet Needs, KOL’s views, Analyst’s views, Checkpoint Inhibitor Refractory Cancer Market Access and Reimbursement

To know more about Checkpoint Inhibitor Refractory Cancer companies working in the treatment market, visit @ Checkpoint Inhibitor Refractory Cancer Clinical Trials and Therapeutic Assessment

Table of Contents

1. Checkpoint Inhibitor Refractory Cancer Market Report Introduction

2. Executive Summary for Checkpoint Inhibitor Refractory Cancer

3. SWOT analysis of Checkpoint Inhibitor Refractory Cancer

4. Checkpoint Inhibitor Refractory Cancer Patient Share (%) Overview at a Glance

5. Checkpoint Inhibitor Refractory Cancer Market Overview at a Glance

6. Checkpoint Inhibitor Refractory Cancer Disease Background and Overview

7. Checkpoint Inhibitor Refractory Cancer Epidemiology and Patient Population

8. Country-Specific Patient Population of Checkpoint Inhibitor Refractory Cancer

9. Checkpoint Inhibitor Refractory Cancer Current Treatment and Medical Practices

10. Checkpoint Inhibitor Refractory Cancer Unmet Needs

11. Checkpoint Inhibitor Refractory Cancer Emerging Therapies

12. Checkpoint Inhibitor Refractory Cancer Market Outlook

13. Country-Wise Checkpoint Inhibitor Refractory Cancer Market Analysis (2019–2032)

14. Checkpoint Inhibitor Refractory Cancer Market Access and Reimbursement of Therapies

15. Checkpoint Inhibitor Refractory Cancer Market Drivers

16. Checkpoint Inhibitor Refractory Cancer Market Barriers

17. Checkpoint Inhibitor Refractory Cancer Appendix

18. Checkpoint Inhibitor Refractory Cancer Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

About DelveInsight

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Checkpoint Inhibitor Refractory Cancer Market Anticipated to Expand Rapidly During 2023-2032, Says DelveInsight | Checkmate Pharma, BIOCAD, 3D Medicines, OncoSec Medical, CatalYm, BerGenBio

How Authors Can Leverage Google Books to the MAX, according to Book Publicist Scott Lorenz

Plymouth, MI, USA – June 16, 2025 – “As technology continues to evolve, digital promotion has become a highly effective tool for authors,” says Scott Lorenz, President of Westwind Communications. “It’s fast, accessible, and offers the potential to reach a global audience at the click of your fingertips.” Platforms like Google Books empower authors to showcase their work and drive sales by building online visibility.

Google Books is a vast digital library where users can search, preview, purchase or borrow from a collection of over 10 million titles. Each book has its own reference page complete with relevant information such as reviews and web references, making it easy for readers to find the content they’re looking for. Google Books sources through two main avenues: the Partner Program, which features titles provided by publishers and authors, and the Library Project, which consists of digitized works from major libraries worldwide. Google Books takes book marketing to the next level.

“Here’s how authors can tap into the power of Google Books,” says Lorenz.

Authors and publishers can submit their work free of charge via the Play Books Partner Center, allowing them to sell books on the Play Store and offer previews on Google Books. Or, if you do not wish to list your book for sale on Google Play, it can still be previewed through Google Books. To check if your publisher has already submitted your book, simply search by title or author name. If it appears in the results, it has likely been added to the site.

The Library Project provides users access to rare, out of print, or multilingual books that are generally unavailable outside of the system. Even if your title is no longer in circulation, it can still participate in Google Books through this initiative. To make your book searchable to users, it must be scanned and converted to a digital format. If you choose to opt out of scanning, only basic bibliographic information- similar to a library catalog entry- will be displayed on the platform.

If you designate your book as public domain, Google will make the text freely accessible to readers from start to finish. Otherwise, the system will only allow users to see blurbs limited to the keywords they search. To ensure your title is protected, publishers should implement your preferred level of digital rights management (DRM) and publish an official copyright notice to clearly state your ownership. Google uses copyright protection to prevent unauthorized use of eBooks, and the extent of access to your book (ranging from 20% to full access) is dictated by the rightsholder.

According to Lorenz, Google Books does not support direct links from individual book pages to external websites, but you can utilize the Partner Program to provide a link to your site when listing a book for sale. You can also add your website link to your author profile to help readers discover more about your work.

“An ISBN is a 13-digit code that uniquely identifies a book and its specific edition, whether it’s hardcover, paperback, or eBook,” says Lorenz. While you do not need one for independent print sales, an ISBN is required for distribution on online platforms such as Google Books. Also, it can open more doors for your book by improving discoverability to maximize sales potential.

Lorenz advises authors to “Focus on non-fiction—self-help, business, technical guides, and travel books tend to perform best. That said, genre fiction like romance, thrillers, and sci-fi can thrive with strong promotion. Audiobooks are also an option, but only for select partners.”

“The key to success?” questions Lorenz, “Optimize metadata, run promotions, and target Android users across dozens of countries. While Google Play has less competition than Amazon, it still demands active marketing to generate sales.” In general, non-fiction outshines fiction in performance. Lorenz continues, “a smart approach is to experiment with free series starters and bonus content to boost visibility.”

“This is how Google Books fits into the big picture,” says Lorenz.

Here’s a breakdown of market share of the top booksellers:

1. Amazon – 50% of all book sales.

2. Barnes & Noble – 5-10% of the market.

3. Books-A-Million – 1-3% share.

4. Walmart – 5-7% of sales.

5. Target – 2-4% of the market.

6. Indie Bookstores – Collectively 5-7% of book sales.

7. Apple Books – 3-5% of the market.

8. Google Play Books – 1-3% share.

9. Audible (Amazon-owned) – 60% of audiobook sales.

10. Book Depository (Amazon-owned) – A global book retailer with a niche market share.

Lorenz’s bottom line: “Don’t miss the chance to expand your reach- submit your book to Google Books! Start leveraging this powerful platform to connect with readers and make your work seen.”

About Book Publicist Scott Lorenz

Book publicist Scott Lorenz is President of Westwind Communications, a public relations and marketing firm that has a special knack for working with authors to help them get all the publicity they deserve and more. Lorenz works with bestselling authors and self-published authors promoting all types of books, whether it’s their first book or their 15th book. He’s handled publicity for books by CEOs, CIA Officers, Navy SEALS, Homemakers, Fitness Gurus, Doctors, Lawyers and Adventurers. His clients have been featured by Good Morning America, FOX & Friends, CNN, ABC News, New York Times, Nightline, TIME, PBS, LA Times, USA Today, Washington Post, Woman’s World, & Howard Stern to name a few.

Learn more about Westwind Book Marketing at https://www.WestwindBookMarketing.com or contact Lorenz at scottlorenz@westwindcos.com or 734-667-2090. Follow Lorenz on Twitter @aBookPublicist. Want help titling a book? Check out Scott Lorenz’s new award-winning, bestselling book: Book Title Generator – A Proven System in Naming Your Book (www.BookTitleGenerator.net).

Media Contact
Company Name: Westwind Communications Book Marketing
Contact Person: Scott Lorenz
Email: Send Email
Phone: 734-667-2090
Country: United States
Website: https://www.WestwindBookMarketing.com